Trial intelligence / Profile preview

Tacrolimus in Membranous Lupus Nephritis

NCT00125307Phase 4Completed

Sponsor
The Chinese University of Hong Kong
Start
Jan 2004
Primary completion
Oct 2007
Modality
RNA-Targeting Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tacrolimus in lupus membranous nephropathy (LMN), sponsored by The Chinese University of Hong Kong. Started Jan 2004; status: completed.

02

Drugs

tacrolimus
03

Conditions

lupus membranous nephropathy (LMN)

Beyond the preview

Go deeper on NCT00125307.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00125307.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call